These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 10488948)

  • 21. High density associated enzymes: their role in vascular biology.
    Navab M; Hama SY; Hough GP; Hedrick CC; Sorenson R; La Du BN; Kobashigawa JA; Fonarow GC; Berliner JA; Laks H; Fogelman AM
    Curr Opin Lipidol; 1998 Oct; 9(5):449-56. PubMed ID: 9812199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reverse cholesterol transport: high-density lipoprotein's magnificent mile.
    Toth PP
    Curr Atheroscler Rep; 2003 Sep; 5(5):386-93. PubMed ID: 12911849
    [No Abstract]   [Full Text] [Related]  

  • 23. Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.
    Lindholm EM; Bielicki JK; Curtiss LK; Rubin EM; Forte TM
    Biochemistry; 1998 Apr; 37(14):4863-8. PubMed ID: 9538003
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro formation of HDL-2 from HDL-3 and triacylglycerol-rich lipoproteins by the action of lecithin:cholesterol acyltransferase and cholesterol ester transfer protein.
    Zechner R; Dieplinger H; Steyrer E; Groener J; Calvert D; Kostner GM
    Biochim Biophys Acta; 1987 Mar; 918(1):27-35. PubMed ID: 3828365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrolysis of phosphatidylcholine by hepatic lipase in discoidal and spheroidal recombinant high-density lipoprotein.
    Tansey JT; Thuren TY; Jerome WG; Hantgan RR; Grant K; Waite M
    Biochemistry; 1997 Oct; 36(40):12227-34. PubMed ID: 9315860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of apolipoprotein A-I-containing lipoproteins in IDDM.
    Kahri J; Groop PH; Viberti G; Elliott T; Taskinen MR
    Diabetes; 1993 Sep; 42(9):1281-8. PubMed ID: 8349039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Remodeling of HDL containing apoA-I but not apoA-II (LpA-I) by lipoprotein-deficient plasma and hepatic lipase: its effect on the structure and cellular cholesterol-reducing capacity of LpA-I.
    Ohta T; Ikeda Y; Hattori S; Matsuda I
    Biochim Biophys Acta; 1996 Sep; 1303(2):137-44. PubMed ID: 8856043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma phospholipid mass transfer rate: relationship to plasma phospholipid and cholesteryl ester transfer activities and lipid parameters.
    Cheung MC; Wolfbauer G; Albers JJ
    Biochim Biophys Acta; 1996 Sep; 1303(2):103-10. PubMed ID: 8856039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
    Tan KC; Shiu SW; Pang RW; Kung AW
    Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-IMilano dimer.
    Calabresi L; Canavesi M; Bernini F; Franceschini G
    Biochemistry; 1999 Dec; 38(49):16307-14. PubMed ID: 10587455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction of model discoidal complexes of phosphatidylcholine and apolipoprotein A-I with plasma components. Physical and chemical properties of the transformed complexes.
    Nichols AV; Gong EL; Blanche PJ; Forte TM; Shore VG
    Biochim Biophys Acta; 1984 May; 793(3):325-37. PubMed ID: 6424716
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lp A-I and niacin: new views of an antiatherogenic duo.
    Saucan L; Brinton EA
    Arterioscler Thromb Vasc Biol; 2001 Nov; 21(11):1707-9. PubMed ID: 11701453
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential additive effects of endothelial lipase and scavenger receptor-class B type I on high-density lipoprotein metabolism in knockout mouse models.
    Ma K; Forte T; Otvos JD; Chan L
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):149-54. PubMed ID: 15539616
    [TBL] [Abstract][Full Text] [Related]  

  • 34. LCAT-dependent conversion of prebeta1-HDL into alpha-migrating HDL is severely delayed in hemodialysis patients.
    Miida T; Miyazaki O; Hanyu O; Nakamura Y; Hirayama S; Narita I; Gejyo F; Ei I; Tasaki K; Kohda Y; Ohta T; Yata S; Fukamachi I; Okada M
    J Am Soc Nephrol; 2003 Mar; 14(3):732-8. PubMed ID: 12595510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Displacement of apo A-I from HDL by apo A-II or its C-terminal helix promotes the formation of pre-beta1 migrating particles and decreases LCAT activation.
    Labeur C; Lambert G; Van Cauteren T; Duverger N; Vanloo B; Chambaz J; Vandekerckhove J; Castro G; Rosseneu M
    Atherosclerosis; 1998 Aug; 139(2):351-62. PubMed ID: 9712342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.
    Riemens S; van Tol A; Sluiter W; Dullaart R
    Atherosclerosis; 1998 Sep; 140(1):71-9. PubMed ID: 9733217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mechanism of human plasma phospholipid transfer protein-induced enlargement of high-density lipoprotein particles: evidence for particle fusion.
    Lusa S; Jauhiainen M; Metso J; Somerharju P; Ehnholm C
    Biochem J; 1996 Jan; 313 ( Pt 1)(Pt 1):275-82. PubMed ID: 8546695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on LCAT, PLTP, and CETP in plasma and peripheral lymph in humans.
    Kujiraoka T; Nanjee MN; Oka T; Ito M; Nagano M; Cooke CJ; Takahashi S; Olszewski WL; Wong JS; Stepanova IP; Hamilton RL; Egashira T; Hattori H; Miller NE
    Arterioscler Thromb Vasc Biol; 2003 Sep; 23(9):1653-9. PubMed ID: 12893687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very high density lipoproteins induced by plasma cholesteryl ester transfer protein (CETP) have a potent antiatherogenic function.
    Yamashita S; Ishigami M; Arai T; Sakai N; Hirano K; Kameda-Takemura K; Tokunaga K; Matsuzawa Y
    Ann N Y Acad Sci; 1995 Jan; 748():606-8. PubMed ID: 7695214
    [No Abstract]   [Full Text] [Related]  

  • 40. Overexpression of apolipoprotein AII in transgenic mice converts high density lipoproteins to proinflammatory particles.
    Castellani LW; Navab M; Van Lenten BJ; Hedrick CC; Hama SY; Goto AM; Fogelman AM; Lusis AJ
    J Clin Invest; 1997 Jul; 100(2):464-74. PubMed ID: 9218525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.